Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
about
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyAngiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.Oxygen, oxidative stress, hypoxia, and heart failure.Experimental therapies in hypertrophic cardiomyopathyStatins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.Buckwheat Rutin Inhibits AngII-induced Cardiomyocyte Hypertrophy via Blockade of CaN-dependent Signal Pathway.Statins: a perspective for left ventricular hypertrophy treatment.Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin.Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient ratsGenetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneys.Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMCRenin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.Effect of Coenzyme Q10 Supplementation in Statin-Treated Obese RatsReactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivoAre statins effective for simultaneously treating dyslipidemias and hypertension?Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoproteinMultiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.Does reversal of oxidative stress and inflammation provide vascular protection?Diabetic microvascular complications: possible targets for improved macrovascular outcomesThe antihypertensive actions of statins: modulation by salt intake.Oxidative stress in patients with cardiovascular disease and chronic renal failure.Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I.Recent advances in genetics and treatment of hypertrophic cardiomyopathy.Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heartSimvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.Simvastatin prevents ERK activation in myocardial hypertrophy of spontaneously hypertensive rats.Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin.Statins and modulation of oxidative stress.Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice.Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.Cardiorenal abnormalities associated with high sodium intake: correction by spironolactone in rats.Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium canrenoate.Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension.Oral simvastatin reduces the hypertensive response to air-jet stress.Statins up-regulate SmgGDS through β1-integrin/Akt1 pathway in endothelial cells.Angiotensin II, Oxidative Stress, and Sympathetic Nervous System Hyperactivity in Heart Failure.
P2860
Q26765793-2BCD24CB-5037-4B9C-9C42-BB8B98A26F17Q30428077-9BD5C2EA-0303-4070-9DEA-986460C87638Q33683779-B81584F3-F8E4-4704-A1FD-AA0104F453A9Q33997765-82555002-113D-4612-8995-EBD5457E65DEQ34429685-AA0F54E7-5B51-4B67-B54B-A4DE4C981EA4Q34515990-EBAB3C08-F073-4BEE-A346-7C4CB35729FDQ34662787-3CBC08E0-73B8-47E1-B861-2381FD5563F1Q34759691-F350F6F9-D401-414A-80E7-5BAA247D7C60Q35179736-F1F95F6A-2211-4AFB-92FE-D340B928B7AFQ35944692-C070B8C2-82D4-42D5-9143-CD032E4BFE6FQ36260730-97D3C7B7-19EA-4C3E-991A-81AC72A69EBCQ36410456-FC46AD50-3BD2-4545-BAE4-9BC7CD2BB7B7Q36640423-3A39EC4A-A3D7-45BF-82AA-F4106C0D0F86Q36761895-094BEF2D-7EBE-42B8-8F85-4AD4AD4AB587Q36896062-B0A21381-B1EC-41E6-9E53-7DA05919CF70Q37078834-C1F2AFE2-3F8A-4BF0-A486-A428B0003C2EQ37247753-5A21CB36-4F80-4C88-8D6F-EFCFB9AE9A24Q37355471-F44CE4F8-9D84-4C18-AD1C-5D1DDEF750EAQ37892915-747F47A2-CEC6-4AD3-A012-2F1C01871341Q38029526-CA32750C-7521-42E5-888A-EA3BD42C342BQ38084417-37D05EFB-21C4-4670-B33C-C2A74CA7A54FQ38093866-63F39D8A-D655-4734-9782-1437D34073EDQ38735223-152733A0-972C-455F-80A0-2EF0B5617AC2Q38806114-0D1A1118-AC46-4034-8763-1FBD9CBBDA30Q39367648-6335B907-9CEC-411C-972C-4850CFAB5FB4Q41813922-424632AA-5952-40F5-9181-108F3072C3D7Q42788177-55978D24-2A86-4D60-B788-E450F5C301F5Q42809818-A16925A5-09C3-4C44-8F37-36CD34AA94FCQ42816496-902EC3C5-5487-4057-983D-6F4504D62310Q43215640-47B7879D-6F3F-416C-9154-AD665A8F04F6Q44886433-8B84B522-45D9-460E-88EF-F5899C8EBF49Q46151507-F73F89D6-0A1B-4E8A-A9DD-96F7F029F92EQ46213897-DE32D413-F2C2-4363-A2F5-A2E3AC6CDE29Q46513164-A77B6E45-1698-4BDD-A962-80D69B5D8775Q46727871-16FEEEB7-05B8-4EC7-BA2F-E975966DA01EQ46982039-97CF87A3-B209-4124-95C2-DF82127C5C63Q48719262-7AD8BF70-C06F-4550-969B-71FFA994912EQ54232373-6F41DFAC-CA92-47F6-867E-05974FCCAE4DQ55365740-D722AD92-8CF0-4A36-BF99-3DBF60C6EE69
P2860
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@en
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@nl
type
label
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@en
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@nl
prefLabel
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@en
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@nl
P2093
P1433
P1476
Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.
@en
P2093
Albert Mimran
Bernard Descomps
Bernard Jover
Jean-Paul Cristol
P304
P356
10.1161/01.HYP.0000024348.87637.6F
P407
P577
2002-08-01T00:00:00Z